Literature DB >> 21618590

Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms.

Meng-Meng Cao1, Wang-Xiang Xu, Chang-Yan Li, Chuan-Zeng Cao, Zhi-Dong Wang, Jia-Wei Yao, Miao Yu, Yi-Qun Zhan, Xiao-Hui Wang, Liu-Jun Tang, Hui Chen, Wei Li, Chang-Hui Ge, Xiao-Ming Yang.   

Abstract

Hepassocin (HPS) is a specific mitogenic active factor for hepatocytes, and inhibits growth by overexpression in hepatocellular carcinoma (HCC) cells. However, the mechanism of HPS regulation on growth of liver-derived cells still remains largely unknown. In this study, we found that HPS was expressed and secreted into the extracellular medium in cultured L02 human hepatic cells; conditional medium of L02 cells promoted proliferation of L02 cells and this activity could be blocked by anti-HPS antibody. Moreover, we identified the presence of receptor for HPS on L02 cells and HepG2 human hepatoma cells. Overproduction of truncated HPS, which signal peptide was deleted, significantly inhibited the proliferation of HCC cells and induced cell cycle arrest. These findings suggest that HPS promotes hepatic cell line L02 cells proliferation via an autocrine mechanism and inhibits HCC cells proliferation by an intracrine pathway.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618590     DOI: 10.1002/jcb.23202

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

1.  Sustained endoplasmic reticulum stress inhibits hepatocyte proliferation via downregulation of c-Met expression.

Authors:  Yihuai He; Jun Long; Weiwei Zhong; Yu Fu; Ying Li; Shide Lin
Journal:  Mol Cell Biochem       Date:  2014-01-05       Impact factor: 3.396

2.  Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.

Authors:  Hamed Nayeb-Hashemi; Anal Desai; Valeriy Demchev; Roderick T Bronson; Jason L Hornick; David E Cohen; Chinweike Ukomadu
Journal:  Biochem Biophys Res Commun       Date:  2015-07-28       Impact factor: 3.575

3.  A Double-Antibody Sandwich ELISA for Sensitive and Specific Detection of Swine Fibrinogen-Like Protein 1.

Authors:  Xin Zhang; Haipeng Zhu; Xu Zheng; Yunjie Jiao; Lulu Ning; En-Min Zhou; Yang Mu
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

4.  Identification of molecular signatures involved in radiation-induced lung fibrosis.

Authors:  Hee Jin; Ga-Young Kang; Seulgi Jeon; Jin-Mo Kim; You Na Park; Jaeho Cho; Yun-Sil Lee
Journal:  J Mol Med (Berl)       Date:  2018-11-07       Impact factor: 4.599

5.  Plasma Fibrinogen-Like 1 as a Potential Biomarker for Radiation-Induced Liver Injury.

Authors:  Na-Kyung Han; Myung Gu Jung; Ye Ji Jeong; Yeonghoon Son; Su Chul Han; Seungwoo Park; Young-Bin Lim; Yoon-Jin Lee; Sung-Ho Kim; Su Cheol Park; Hae-June Lee
Journal:  Cells       Date:  2019-09-06       Impact factor: 6.600

6.  Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells.

Authors:  Yeonghoon Son; Na-Rae Shin; Sung-Ho Kim; Su-Cheol Park; Hae-June Lee
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

7.  RMP plays distinct roles in the proliferation of hepatocellular carcinoma cells and normal hepatic cells.

Authors:  Sijun Yang; Hongmin Wang; Yunlan Guo; Shaomu Chen; Mei-Yin Zhang; Jian Shen; Huijun Yu; Jingcheng Miao; Hui-Yun Wang; Wenxiang Wei
Journal:  Int J Biol Sci       Date:  2013-07-05       Impact factor: 6.580

8.  The sea cucumber genome provides insights into morphological evolution and visceral regeneration.

Authors:  Xiaojun Zhang; Lina Sun; Jianbo Yuan; Yamin Sun; Yi Gao; Libin Zhang; Shihao Li; Hui Dai; Jean-François Hamel; Chengzhang Liu; Yang Yu; Shilin Liu; Wenchao Lin; Kaimin Guo; Songjun Jin; Peng Xu; Kenneth B Storey; Pin Huan; Tao Zhang; Yi Zhou; Jiquan Zhang; Chenggang Lin; Xiaoni Li; Lili Xing; Da Huo; Mingzhe Sun; Lei Wang; Annie Mercier; Fuhua Li; Hongsheng Yang; Jianhai Xiang
Journal:  PLoS Biol       Date:  2017-10-12       Impact factor: 8.029

9.  FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.

Authors:  Cuilan Sun; Weiwei Gao; Jiatao Liu; Hao Cheng; Jiqing Hao
Journal:  Respir Res       Date:  2020-08-10

Review 10.  Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms.

Authors:  Hirokazu Takahashi; Kazuhiko Kotani; Kenichi Tanaka; Yuichiro Egucih; Keizo Anzai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-15       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.